Clinical Clues in Cardiovascular Disease: Enhancing Detection and Patient Monitoring

  • Published:  04 September 2025
  • Likes: 

    Heart Icon

    0

Clinical Clues in Cardiovascular Disease: Enhancing Detection and Patient Monitoring

  • Published:  04 September 2025
  • Likes: 

    Heart Icon

    0

Average (ratings)
No ratings
Your rating
About the episode

Prof Alta Schutte (University of New South Wales, Sydney, Australia) highlights the value of home-based screening for blood pressure and atrial fibrillation. With limited time in primary care, many cases go undetected – yet validated home devices can reliably measure both conditions. Prof Schutte stresses the importance of using only clinically validated monitors, training patients in accurate measurement, and incorporating home data into routine practice. Early detection at home offers a practical, guideline-endorsed way to improve diagnosis and outcomes.

Overview

This six-part interview series, recorded around ESC 2025, brings together leading experts to share strategies for earlier and more accurate detection of cardiovascular disease. The discussions highlight how atypical or subtle symptoms of stroke and heart failure can delay diagnosis, and why vigilance in routine practice is critical.

 

The series also examines sex-specific differences in cardiac anatomy, the role of validated home blood pressure and pulse-monitoring devices in guideline-directed screening, and the value of simple tests such as ECG. Collectively, these insights underline the importance of timely recognition and intervention to prevent progression to stroke and heart failure, and to improve patient outcomes.

 

This series relates to the ESC 2025 symposium Recognising Undiagnosed Heart Failure in Women, also available on-demand.

 

This interview series is supported by

More from this programme

Part 1

Beyond the Usual: Atypical Heart Failure and Stroke Symptoms

Prof Renate Schnabel (University Heart Center Hamburg, Hamburg, DE) discusses the importance of recognising atypical presentations of stroke and heart failure. Beyond well-known signs, patients – particularly older adults, women, and those with co-morbidities – may show subtle symptoms such as confusion, vertigo, vomiting, or loss of appetite. Early recognition is critical: stroke is always an emergency, and delayed heart failure diagnosis worsens outcomes. Prof Schnabel calls for vigilance, simple diagnostic testing and clear pathways to ensure timely evaluation and treatment.

Part 2

Detect Early, Act Early: Home Screening of Blood Pressure and AF

Prof Alta Schutte (University of New South Wales, Sydney, Australia) highlights the value of home-based screening for blood pressure and atrial fibrillation. With limited time in primary care, many cases go undetected – yet validated home devices can reliably measure both conditions. Prof Schutte stresses the importance of using only clinically validated monitors, training patients in accurate measurement, and incorporating home data into routine practice. Early detection at home offers a practical, guideline-endorsed way to improve diagnosis and outcomes.

Part 3

Cardiac Anatomy: Male vs Female

Prof Eva Gerdts (University of Bergen, Norway) explores key sex differences in cardiac structure and their impact on diagnosis. Women generally have smaller hearts and arteries, requiring sex-specific thresholds to accurately detect hypertrophy and atrial enlargement. Misinterpretation can delay recognition of early, reversible organ damage. Prof Gerdts also stresses that women’s symptoms, such as breathlessness, are often dismissed as lifestyle-related, leading to underdiagnosis. Objective testing and awareness of sex-specific differences are essential for timely cardiovascular prevention and care.

 

Part 4

Silent Signals: Reduce Stroke And Heart Failure Risk Via Screening

Prof Eva Gerdts (University of Bergen, Norway) underscores the importance of early blood pressure screening to prevent stroke and heart failure. Hypertension remains the leading cardiovascular risk factor, yet annual checks from age 40 – ideally with devices that also record pulse – are often overlooked. Prof Gerdts highlights that early treatment can cut stroke risk by up to 70% and substantially lower heart failure risk. She advises clinicians to take patient-reported high readings or irregular rhythms seriously, confirm with ECG and standardised blood pressure measurement, and refer promptly when needed.

Part 5

The Missed Patient Case: Early Clues in Heart Failure and Stroke – Part 1

In this peer-to-peer discussion, Dr Yassir Javaid (Northamptonshire, UK) and Prof Faizel Osman (University Hospitals Coventry and Warwickshire, UK) explore the challenge of missed diagnoses in atrial fibrillation, heart failure and stroke. They stress the need for opportunistic screening in primary care, as many patients are asymptomatic or misattribute symptoms.

Part 6

The Missed Patient Case: Early Clues in Heart Failure and Stroke – Part 2

In this second part of the discussion, Dr Yassir Javaid (Northamptonshire, UK) and Prof Faizel Osman (University Hospitals Coventry and Warwickshire, UK) consider portable and integrated devices, such as blood pressure monitors with ECG, can support earlier detection. Timely anticoagulation and early rhythm control are key to stroke prevention and better outcomes, with integrated care models helping to streamline pathways.

Part 7

Empowering Patients with Home ECG & BP Monitoring

Dr Yassir Javaid (Northampton, UK) explains how home blood pressure and ECG monitoring can improve cardiovascular prevention. Hypertension and atrial fibrillation are common, often silent and major drivers of stroke and heart failure. Remote self-monitoring provides accurate data, speeds diagnosis and empowers patients. With proper training and timely review, integrated BP and ECG devices enable earlier detection and better outcomes.

Faculty Biographies

Alta  Schutte

Alta Schutte

Faculty of Medicine and Health at UNSW Sydney, Australia

Prof Alta Schutte is a Professor and Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine in the Faculty of Medicine and Health at UNSW Sydney, Australia; with a joint appointment as Professorial Fellow at the George Institute for Global Health. Prof Schutte has extensive experience in working in clinical and population-based studies with a focus on raised blood pressure, hypertension and cardiovascular disease. She is involved in numerous international consortia, such as the Global Burden of Disease study, the NCD Risk Factor Collaboration and the May Measurement Month initiative of the International Society of Hypertension. Her expertise includes the management of hypertension and monitoring of raised blood pressure, actions and interventions to improve blood pressure control and the detection, treatment and control of hypertension.

 

View full profile